ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $18,000 | +50.0% | 950 | -4.8% | 0.00% | – |
| Q2 2019 | $12,000 | -14.3% | 998 | 0.0% | 0.00% | – |
| Q1 2019 | $14,000 | +27.3% | 998 | -11.8% | 0.00% | – |
| Q4 2018 | $11,000 | -38.9% | 1,131 | 0.0% | 0.00% | – |
| Q3 2018 | $18,000 | +12.5% | 1,131 | +13.3% | 0.00% | – |
| Q2 2018 | $16,000 | +14.3% | 998 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | 0.0% | 998 | -10.6% | 0.00% | – |
| Q4 2017 | $14,000 | +27.3% | 1,116 | +28.9% | 0.00% | – |
| Q3 2017 | $11,000 | +10.0% | 866 | +0.5% | 0.00% | – |
| Q2 2017 | $10,000 | -23.1% | 862 | +37.9% | 0.00% | – |
| Q1 2017 | $13,000 | +44.4% | 625 | +44.7% | 0.00% | – |
| Q4 2016 | $9,000 | +28.6% | 432 | +137.4% | 0.00% | – |
| Q3 2016 | $7,000 | +250.0% | 182 | +71.7% | 0.00% | – |
| Q2 2016 | $2,000 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |